Results 241 to 250 of about 2,899,588 (264)

Adherence to adjuvant endocrine therapy in breast cancer: a single regional Australian centre experience. [PDF]

Front Oncol
Bu D, Sahu A, Torres J.
europepmc   +1 more source

Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register- based matched cohort study. [PDF]

BMC Cancer
Schiza A, Digkas E, Papadopoulos F, Skalkidou A, Elenis E.   +4 more
europepmc   +1 more source

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial. [PDF]

Nat Commun
Matikas A, Tzoras E, Sarafidis M, Sifakis EG, Bjöhle J, Barnekow E, Margolin S, Isaksson-Friman E, Kessler LE, Zouzos A, Johansson H, Hellström M, Agartz S, Grybäck P, Salgkamis D, Zerdes I, Wang K, Hartman J, Acs B, Sun W, Boyaci C, Villacampa G, Pascual T, Gavila J, Prat A, Perou C, Brandberg Y, Bergh J, Hatschek T, Foukakis T.   +29 more
europepmc   +1 more source

Assessing Racial Differences in Psychological Distress and Problem Items among Breast Cancer Survivors at Adjuvant Endocrine Therapy Initiation. [PDF]

Clin Breast Cancer
Tariq F, Taylor T, Bastaich D, Sheppard VB.   +3 more
europepmc   +1 more source

Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients—Review and Perspectives

Cancers, 2023
SIMPLE SUMMARY: Five years of therapy remains the standard for adjuvant endocrine therapy in early breast cancer. However, the recurrence risk remains elevated beyond this time period.
Inga Bekes, Jens Huober
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Hope Rugo, Özge Gümüşay, Laura A Huppert   +2 more
exaly  

Mechanisms of endocrine therapy resistance in breast cancer

Molecular and Cellular Endocrinology, 2021
Kevin Pruitt, Fahmida Akter Rasha
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer†

Ca-A Cancer Journal for Clinicians, 2005
Ruth M O'Regan, R M O'Regan
exaly  

Medullary thyroid carcinoma: A component of an interesting endocrine syndrome

Ca-A Cancer Journal for Clinicians, 1969
Melvin A Block
exaly